Ghrelin shows promise for treating cancer cachexia through combined appetite stimulation, GH-mediated anabolism, and anti-inflammatory effects — addressing the multi-factorial wasting that kills many cancer patients.
Key findingGhrelin addresses cancer cachexia through triple mechanism: appetite stimulation (reversing anorexia), GH/IGF-1-mediated anabolism (opposing muscle wa
What the researchers found
Ghrelin addresses cancer cachexia through triple mechanism: appetite stimulation (reversing anorexia), GH/IGF-1-mediated anabolism (opposing muscle wasting), and anti-inflammatory effects (countering inflammatory cytokine-driven catabolism) — emerging as the most comprehensive cachexia therapy.
Why it matters
Relevant for ghrp, cancer, weight-loss.
How the study worked
review study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Emergence of ghrelin as a treatment for cachexia syndromes.
Nutrition (Burbank, Los Angeles County, Calif.), 24(9), 806-14
Citation
DeBoer, Mark Daniel. (2008). Emergence of ghrelin as a treatment for cachexia syndromes.. Nutrition (Burbank, Los Angeles County, Calif.), 24(9), 806-14. https://doi.org/10.1016/j.nut.2008.06.013